JPRN-UMIN000034383已完成3 期
The efficacy of combination antiemetic therapy with Olanzapine, Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving Moderately Emetogenic Chemotherapy - The efficacy of Olanzapine for MEC
Osaka Medical Collage0 个研究点目标入组 150 人开始时间: 2018年10月4日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •"A history of allergy to drugs and similar compounds used in this study Patients who do not have general condition that can endure chemotherapy History of symptomatic brain metastasis or gastrointestinal obstruction nausea and vomiting within 24 hours before chemotherapy A history of diabetes, or HbA1c(NGSP)>6.5% or HbA1c(JDS)>6.1 %"
研究者
相似试验
已完成
2 期
The efficacy and safety of antiemetic therapy for carboplatin-containing chemotherapy-induced nausea and vomiting in patients with lung cancer.advanced lung cancerJPRN-UMIN000026739Second Division, Department of Internal Medicine, Hamamatsu university school of medicine30
尚未招募
Unknown
Comparing Injection Palonosetron alone and Palonosetron with Dexamethasone for preventing vomiting in post operation period in cholecystectomy patientsCTRI/2023/11/059627Dr SHIVAKUMAR G
撤回
不适用
The effectiveness of alternative antiemetic therapies in patients with cancer and nausea not related to cancer therapyACTRN12610000482066Professor Patsy Yates272
已完成
不适用
The effectiveness of guideline driven antiemetic therapy versus single agent antiemetic therapy in patients with cancer and nausea not related to cancer therapy.ausea in the setting of advanced cancer not related to anticancer therapyNausea in the setting of advanced cancer not related to anticancer therapyCancer - Other cancer typesACTRN12610000481077Professor Patsy Yates216
已完成
2 期
Clinical evaluation of two antiemetic combinations palonosetron dexamethazone in paclitaxel and carboplatin: a randomized phase II trial.patients with gynecological malignancies who are receiving paclitaxel/carboplatin.JPRN-UMIN000007491ara Medical University80